Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed May 12, 2022 · 10-Q · 42 days after period end · 0001564590-22-019876
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$7.57M | -$8.00M | -$3.32M | -$5.90M |
| EPS Diluted | -$0.80 | -$1.30 | -$2.15 | -$17.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 12, 2022 · 42 d after period end
